# Task C21: Compound Synthesis - Nonclinical Services for Development of Interventional Agents for Infectious Diseases

> **NIH NIH N01** · ALBANY MOLECULAR RESEARCH, INC. · 2022 · $1,056,500

## Abstract

This contract provides for chemistry and manufacturing services under the NIAID Preclinical Services for the Development of Interventional Agents Program.

## Key facts

- **NIH application ID:** 10703293
- **Project number:** 272201800008I-0-759302200004-1
- **Recipient organization:** ALBANY MOLECULAR RESEARCH, INC.
- **Principal Investigator:** JIAN-XIE CHEN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,056,500
- **Award type:** —
- **Project period:** 2022-09-01 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10703293

## Citation

> US National Institutes of Health, RePORTER application 10703293, Task C21: Compound Synthesis - Nonclinical Services for Development of Interventional Agents for Infectious Diseases (272201800008I-0-759302200004-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10703293. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*